Opio Jacob, Wynne Katie, Attia John, Hancock Stephen, McEvoy Mark
School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Diabetes and Endocrinology, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.
Nutrients. 2024 Dec 10;16(24):4256. doi: 10.3390/nu16244256.
Few studies have explored the links between adiposity, metabolic health, and lung function. This study examined the cross-sectional association between spirometric lung function and overweight/obesity, with and without metabolic abnormalities, in older adults. The research involved 3,318 older adults from the Hunter Community Study Cohort who had a BMI of 18.5 kg/m or higher. Participants were grouped based on BMI and metabolic health risk. Obesity was defined as a BMI of 30 kg/m or more, while metabolic health was determined by the absence of risk factors according to the International Diabetes Federation criteria. Lung function was assessed via spirometry, measuring FEV1, FVC, predicted FEV1, predicted FVC, and FEV1/FVC ratio. Lung dysfunction was classified into restrictive, obstructive, mixed patterns, and deviations from predicted FEV1 and FVC. The mean lung function measurements were as follows: FEV1 2.4 L (0.7), FVC 2.9 L (0.8), predicted FEV1% 88.7% (17.6), predicted FVC% 85.6% (15.7), and FEV1/FVC 82.5% (8.5). Compared to the metabolically healthy normal weight (MHNW) group, the odds of lung dysfunction were as follows. For the restrictive pattern, the MHOW group had an odds ratio (OR) of 1.00 (95% CI: 0.70-1.47, = 0.959) and the MHO group had an OR of 1.67 (95% CI: 1.13-2.49, = 0.011). For the obstructive pattern, the MHOW group had an OR of 0.39 (95% CI: 0.20-0.77, = 0.007) and the MHO group had an OR of 0.36 (95% CI: 0.12-1.05, = 0.061). For the mixed pattern, the MHOW group had an OR of 0.39 (95% CI: 0.18-0.87, = 0.021) and the MHO group had an OR of 0.29 (95% CI: 0.10-0.87, = 0.027). A higher BMI and variations in metabolic health are associated with an increased likelihood of restrictive lung function patterns. Conversely, obesity is inversely related to obstructive lung function patterns.
很少有研究探讨肥胖、代谢健康和肺功能之间的联系。本研究调查了老年人中肺活量测定的肺功能与超重/肥胖之间的横断面关联,无论是否存在代谢异常。该研究涉及来自亨特社区研究队列的3318名老年人,他们的体重指数(BMI)为18.5千克/平方米或更高。参与者根据BMI和代谢健康风险进行分组。肥胖定义为BMI为30千克/平方米或更高,而代谢健康则根据国际糖尿病联合会的标准,通过不存在风险因素来确定。通过肺活量测定评估肺功能,测量第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、预测FEV1、预测FVC以及FEV1/FVC比值。肺功能障碍分为限制性、阻塞性、混合性模式以及与预测FEV1和FVC的偏差。肺功能测量的平均值如下:FEV1为2.4升(0.7),FVC为2.9升(0.8),预测FEV1%为88.7%(17.6),预测FVC%为85.6%(15.7),FEV1/FVC为82.5%(8.5)。与代谢健康的正常体重(MHNW)组相比,肺功能障碍的比值比(OR)如下。对于限制性模式,超重/肥胖但代谢健康(MHOW)组的OR为1.00(95%置信区间:0.70 - 1.47,P = 0.959),肥胖且代谢健康(MHO)组的OR为1.67(95%置信区间:1.13 - 2.49,P = 0.011)。对于阻塞性模式,MHOW组的OR为0.39(95%置信区间:0.20 - 0.77,P = 0.007),MHO组的OR为0.36(95%置信区间:0.12 - 1.05,P = 0.061)。对于混合性模式,MHOW组的OR为0.39(95%置信区间:0.18 - 0.87,P = 0.021),MHO组的OR为0.29(95%置信区间:0.10 - 0.87,P = 0.027)。较高的BMI和代谢健康的变化与限制性肺功能模式的可能性增加有关。相反,肥胖与阻塞性肺功能模式呈负相关。
Medicine (Baltimore). 2017-4
Am J Kidney Dis. 2017-11
Endocr Metab Immune Disord Drug Targets. 2022
JMIR Public Health Surveill. 2023-9-5
Am J Manag Care. 2022-12
Healthcare (Basel). 2022-8-25
Metab Syndr Relat Disord. 2022-12